Johnson & Johnson (JNJ) Retained Earnings (2009 - 2026)
Johnson & Johnson recorded quarterly Retained Earnings of -$14.8 billion in Q1 2026, down 108.78% quarter-over-quarter from $169.0 billion in Q4 2025, and down 109.12% year-over-year from $162.6 billion in Q1 2025.
Johnson & Johnson's Retained Earnings history runs 18 years deep, the most recent figure standing at -$14.8 billion for Q1 2026.
- In Q1 2026, Retained Earnings fell 109.12% year-over-year to -$14.8 billion; the TTM figure through Mar 2026 stood at -$14.8 billion (down 109.12% YoY), while the FY2025 annual figure was $169.0 billion, up 8.46% from the prior year.
- Retained Earnings came in at -$14.8 billion for Q1 2026 at Johnson & Johnson, down from $169.0 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $169.0 billion in Q4 2025 to a low of -$15.3 billion in Q4 2022.
- A 5-year average of $65.4 billion and a median of $56.6 billion in 2022 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings slumped 111.52% in 2022 and jumped 1343.64% in 2024, its largest moves.
- Johnson & Johnson's Retained Earnings stood at -$15.3 billion in 2022, then rose by 18.08% to -$12.5 billion in 2023, then surged by 1343.64% to $155.8 billion in 2024, then climbed by 8.46% to $169.0 billion in 2025, then sank by 108.78% to -$14.8 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$14.8 billion, $169.0 billion, and -$15.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 29.51 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -14.83 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -17.87 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 66.72 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -190.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 78.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -7.20 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -1.37 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 1.76 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -14.83 Bn |
| Dec 28, 2025 | 168.98 Bn |
| Sep 28, 2025 | -15.24 Bn |
| Jun 29, 2025 | -14.31 Bn |
| Mar 30, 2025 | 162.64 Bn |
| Dec 29, 2024 | 155.79 Bn |
| Sep 29, 2024 | -12.52 Bn |
| Jun 30, 2024 | -11.25 Bn |
| Mar 31, 2024 | 153.38 Bn |
| Dec 31, 2023 | -12.53 Bn |
| Oct 1, 2023 | 152.54 Bn |
| Jul 2, 2023 | 129.38 Bn |
| Apr 2, 2023 | 124.56 Bn |
| Jan 1, 2023 | 128.35 Bn |
| Oct 2, 2022 | -15.29 Bn |
| Jul 3, 2022 | -13.84 Bn |
| Apr 3, 2022 | 124.38 Bn |
| Jan 2, 2022 | -13.06 Bn |
| Oct 3, 2021 | -15.42 Bn |
| Jul 4, 2021 | 120.15 Bn |
| Apr 4, 2021 | 116.51 Bn |
| Jan 3, 2021 | 113.89 Bn |
| Sep 27, 2020 | 114.83 Bn |
| Jun 28, 2020 | 113.90 Bn |
| Mar 29, 2020 | -16.24 Bn |
| Dec 29, 2019 | 110.66 Bn |
| Sep 29, 2019 | -15.53 Bn |
| Jun 30, 2019 | -14.97 Bn |
| Mar 31, 2019 | -15.52 Bn |
| Dec 30, 2018 | 106.22 Bn |
| Sep 30, 2018 | 107.62 Bn |
| Jul 1, 2018 | -14.78 Bn |
| Apr 1, 2018 | 104.34 Bn |
| Dec 31, 2017 | 101.79 Bn |
| Oct 1, 2017 | -12.75 Bn |
| Jul 2, 2017 | 113.21 Bn |
| Apr 2, 2017 | 111.64 Bn |
| Jan 1, 2017 | 110.55 Bn |
| Oct 2, 2016 | -12.72 Bn |
| Jul 3, 2016 | 106.74 Bn |
| Apr 3, 2016 | -12.39 Bn |
| Jan 3, 2016 | -13.17 Bn |
| Sep 27, 2015 | -12.86 Bn |
| Jun 28, 2015 | -12.05 Bn |
| Mar 29, 2015 | 98.66 Bn |
| Dec 28, 2014 | -10.72 Bn |
| Sep 28, 2014 | 96.56 Bn |
| Jun 29, 2014 | 93.75 Bn |
| Mar 30, 2014 | -2.65 Bn |
| Dec 29, 2013 | -2.86 Bn |
| Sep 29, 2013 | 87.70 Bn |
| Jun 30, 2013 | -6.81 Bn |
| Mar 31, 2013 | -6.69 Bn |
| Dec 30, 2012 | -5.81 Bn |
| Sep 30, 2012 | -4.93 Bn |
| Jul 1, 2012 | 83.53 Bn |
| Apr 1, 2012 | 83.10 Bn |
| Jan 1, 2012 | -5.63 Bn |
| Oct 2, 2011 | -3.07 Bn |
| Jul 3, 2011 | -1.19 Bn |
| Apr 3, 2011 | -2.02 Bn |
| Jan 2, 2011 | -3.53 Bn |
| Oct 3, 2010 | -2.92 Bn |
| Jul 4, 2010 | -5.71 Bn |
| Apr 4, 2010 | 73.18 Bn |
| Jan 3, 2010 | -3.06 Bn |
| Sep 27, 2009 | -2.66 Bn |
| Jun 28, 2009 | -4.48 Bn |